Jean-Michel Hannoun-Levi
University of Nice Sophia Antipolis
CancerInternal medicineRadiologyUrologySurgeryOncologyRetrospective cohort studyRandomized controlled trialMedical physicsExternal beam radiotherapyBrachytherapyMastectomyLumpectomyProstate cancerHigh-Dose Rate BrachytherapyPartial Breast IrradiationGynecologyNuclear medicineRadiation therapyBreast cancerMedicine
Publications 210
#2Jocelyn GalH-Index: 16
Last. Vratislav Strnad (FAU: University of Erlangen-Nuremberg)H-Index: 30
view all 19 authors...
Summary Purpose Second conservative treatment has emerged as an option for patients with second ipsilateral breast tumour event after conserving surgery and breast irradiation. We aimed to address the lack of evidence regarding second breast event treatment by comparing oncological outcomes after conservative treatment or mastectomy. Methods and Materials Oncological outcomes were analysed using a propensity score-matched cohort analysis study on patients diagnosed with a second breast event bet...
#1Jean-Pierre GérardH-Index: 46
#2N. BarbetH-Index: 3
Last. Jean-Michel Hannoun-LeviH-Index: 23
view all 9 authors...
Abstract The Papillon experience and the Lyon R96-02 trial have shown that contact X-ray brachytherapy of 50 kV is efficient and safe to achieve long term local control and organ preservation for cT1 and early cT2-3 rectal cancers. The OPERA trial, using the Papillon 50™ machine, brings further support to this preservation strategy for selected T2T3ab lesions. Future trials using a contact X-ray boost will try to consolidate and enlarge its place in organ preservation for rectal cancers.
#2Emmanuel ChamoreyH-Index: 29
Last. Vratislav Strnad (FAU: University of Erlangen-Nuremberg)H-Index: 30
view all 5 authors...
Abstract Purpose Breast cancer in the elderly has become a public health concern; there is a need to re-design its treatment with a view to de-escalation. Our paper sets out the rationale for a phase 3 randomized trial to evaluate less burdensome adjuvant procedures that remain effective and efficient. Materials and methods For low-risk breast cancer in the elderly, adjuvant treatment has been adjusted in order to make it more suitable and efficient. Hypofractionated radiation therapy based on a...
#2Giulia MarvasoH-Index: 14
Last. Piet OstH-Index: 41
view all 36 authors...
Abstract Background and purpose Between 30% and 47% of patients treated with definitive radiotherapy (RT) for prostate cancer are at risk of intraprostatic recurrence during follow-up. Re-irradiation with stereotactic body RT (SBRT) is emerging as a feasible and safe therapeutic option. However, no consensus or guidelines exist on this topic. The purpose of this ESTRO ACROP project is to investigate expert opinion on salvage SBRT for intraprostatic relapse after RT. Materials and Methods A 40-it...
AIM Accelerated partial breast irradiation (APBI) represents a validated technique for low-risk breast cancer. Recently, ultra APBI (uAPBI) using fewer than 5 fractions were described in literature. We compared clinical outcome and late toxicity after APBI or uAPBI in the elderly. MATERIAL/METHODS Two cohorts of elderly (≥ 70 years) low-risk breast cancer treated with APBI (interstitial brachytherapy) were retrospectively analyzed. A total dose of 34Gy/10f (APBI) or 16Gy/1f (uAPBI) was delivered...
1 CitationsSource
#1Nicolas Martz (University of Nice Sophia Antipolis)
#2Y. Bodokh (University of Nice Sophia Antipolis)H-Index: 2
Last. Jean-Michel Hannoun-Levi (University of Nice Sophia Antipolis)H-Index: 23
view all 10 authors...
Abstract Purpose To analyze the oncological outcome and toxicity profile after conservative treatment based on multicatheter interstitial high-dose rate brachytherapy (MHB) for patients presenting a localized penile cancer. Materials and methods Patients with histologically proven, non-metastatic (T1-T2 N0-N2 M0) localized penile cancer were treated with MHB. Needles were placed under general anesthesia into the target volume using a dedicated template. Treatment planning was performed using a p...
#1Jérôme DoyenH-Index: 17
Last. Pierre-Yves BondiauH-Index: 20
view all 18 authors...
Background. The conventional dose rate of radiation therapy is 0.01-0.05 Gy per second. According to preclinical studies, an increased dose rate may offer similar anti-tumoral effect while dramatically improving normal tissue protection. This study aims at evaluating the early toxicities for patients irradiated with high dose rate pulsed proton therapy (PT). Materials and Methods. A single institution retrospective chart review was performed for patients treated with high dose rate (10 Gy per se...